Patent ID: 8951538
Filing Date: 2015-02-10
Classification: A61K,Y02A

Abstract:
1. A pharmaceutical composition, comprising: an effective amount of a polysaccharide, the polysaccharide being Shigella sonnei , phase I polysaccharide, comprising: 1-100 repeating disaccharide units of O-[4-amino-2-(N-acetyl)amino-2,4-dideoxy-β-D-galactopyranosyl]-(1→4)-O-[2-(N-acetyl)amino-2-deoxy-α-L-altrpyranuronic acid] linked within the polysaccharide chain by (1→3) bonds, produced using S. sonnei bacteria, but without using lipopolysaccharides as a source of production, further comprising non-hydroxylated fatty acids.